AstraZeneca
The Drug Substance Tech Transfer Lead leads technology transfer activities across a diverse biologics portfolio, focusing on post-approval transfers and new product introductions. This role ensures robust, reliable commercial manufacturing by supporting Global CMC deliverables and driving transfer readiness across internal and external networks. The position involves collaborating with cross-functional teams to manage risks, embed quality standards, and implement digital tools to improve execution efficiency.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
30% above the average for this role
Associate Scientific Fellow, Upstream Technology Transfer Lead, Drug Substance Operations, Biotherapeutics Process Development, Pharmaceutical Sciences
BioLife Plasma Services
Associate Director CMC Drug Substance
Celldex Therapeutics
Associate Scientific Fellow, Downstream Technology Transfer Lead, Drug Substance Operations, Biotherapeutics Process Development, Pharmaceutical Sciences
BioLife Plasma Services
Director
Eli Lilly and Company
Drug Substance Tech Transfer (TT) Lead
FUJIFILM Diosynth Biotechnologies
Senior Drug Substance Scientist
Zealand Pharma